{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T21:26:49Z","timestamp":1781299609943,"version":"3.54.1"},"reference-count":84,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.berh.2020.101509","type":"journal-article","created":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T07:40:27Z","timestamp":1586763627000},"page":"101509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Opportunistic tropical infections in immunosuppressed patients"],"prefix":"10.1016","volume":"34","author":[{"given":"Patr\u00edcia","family":"Shu Kurizky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leopoldo Luiz","family":"dos Santos Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Barbosa Aires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Licia Maria","family":"Henrique da Mota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Martins Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2020.101509_bib1","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1007\/s00018-016-2311-1","article-title":"Environmental factors in autoimmune diseases and their role in multiple sclerosis","volume":"73","author":"J\u00f6rg","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.berh.2020.101509_bib2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1586\/eci.13.10","article-title":"Immune-mediated inflammatory diseases: progress in molecular pathogenesis and therapeutic strategies","volume":"9","author":"Bayry","year":"2013","journal-title":"Expet Rev Clin Immunol"},{"key":"10.1016\/j.berh.2020.101509_bib3","doi-asserted-by":"crossref","first-page":"J163","DOI":"10.1016\/j.jaut.2009.12.005","article-title":"Geo-epidemiology and autoimmunity","volume":"34","author":"Youinou","year":"2010","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.berh.2020.101509_bib4","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10067-014-2841-6","article-title":"The global challenges and opportunities in the practice of rheumatology: white paper by the World Forum on Rheumatic and Musculoskeletal Diseases","volume":"34","author":"Al Maini","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2020.101509_bib5","doi-asserted-by":"crossref","first-page":"w14159","DOI":"10.4414\/smw.2015.14159","article-title":"Vaccination recommendations for adult patients with autoimmune inflammatory rheumatic diseases","volume":"145","author":"B\u00fchler","year":"2015","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.berh.2020.101509_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/1346-8138.14074","article-title":"Immune reconstitution inflammatory syndrome in non-HIV immunosuppressed patients","volume":"45","author":"Sueki","year":"2018","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.berh.2020.101509_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s42358-019-0056-x","article-title":"Brazilian recommendations on the safety and effectiveness of the yellow fever vaccination in patients with chronic immune-mediated inflammatory diseases","volume":"59","author":"Pileggi","year":"2019","journal-title":"Adv Rheumatol"},{"key":"10.1016\/j.berh.2020.101509_bib8","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1080\/21505594.2015.1021539","article-title":"Climate change-related migration and infectious disease","volume":"6","author":"McMichael","year":"2015","journal-title":"Virulence"},{"key":"10.1016\/j.berh.2020.101509_bib9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/imm.13103","article-title":"Infectious processes and systemic lupus erythematosus","volume":"158","author":"Illescas-Montes","year":"2019","journal-title":"Immunology"},{"key":"10.1016\/j.berh.2020.101509_bib10","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.trstmh.2009.01.014","article-title":"Prevalence of Leishmania infection in adult HIV\/AIDS patients treated in a tertiary-level care center in Brasilia, Federal District, Brazil","volume":"103","author":"Carranza-Tamayo","year":"2009","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.berh.2020.101509_bib11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1590\/S0482-50042012000300014","article-title":"Leishmaniose tegumentar em paciente com espondilite anquilosante utilizando adalimumabe","volume":"52","author":"Gomes","year":"2012","journal-title":"Rev Bras Reumatol"},{"key":"10.1016\/j.berh.2020.101509_bib12","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/1469-0691.12556","article-title":"Leishmaniasis in immunosuppressed individuals","volume":"20","author":"Van Griensven","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.berh.2020.101509_bib13","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1590\/abd1806-4841.20142389","article-title":"Complementary exams in the diagnosis of American tegumentary leishmaniasis","volume":"89","author":"Gomes","year":"2014","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.berh.2020.101509_bib14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12288-015-0541-2","article-title":"Hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis: varied presentation","volume":"32","author":"Ranjan","year":"2016","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.berh.2020.101509_bib15","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.cmi.2018.04.025","article-title":"Accuracy of qPCR for quantifying Leishmania kDNA in different skin layers of patients with American tegumentary leishmaniasis","volume":"25","author":"Sevilha-Santos","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.berh.2020.101509_bib16","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.semarthrit.2014.12.004","article-title":"Visceral leishmaniasis mimicking systemic lupus erythematosus: case series and a systematic literature review","volume":"44","author":"Santana","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2020.101509_bib17","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.reuma.2016.07.005","article-title":"Visceral leishmaniasis in a rheumatoid arthritis patient receiving methotrexate","volume":"13","author":"Reina","year":"2017","journal-title":"Reumatol Cl\u00ednica"},{"key":"10.1016\/j.berh.2020.101509_bib18","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1590\/s1678-9946201759006","article-title":"Reactivation of cutaneous and mucocutaneous tegumentary leishmaniasis in rheumatoid arthritis patients: an emerging problem?","volume":"59","author":"de Souza","year":"2017","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.berh.2020.101509_bib19","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jdcr.2017.09.020","article-title":"Plurifocal cutaneous leishmaniasis during treatment with ustekinumab","volume":"4","author":"Rakotonarivo","year":"2018","journal-title":"JAAD Case Reports"},{"key":"10.1016\/j.berh.2020.101509_bib20","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/bjd.18262","article-title":"Cross-sectional screening study for leishmania DNA and antibodies in biologic-treated psoriasis patients living in an area endemic for leishmaniasis","volume":"181","author":"Kurizky","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.berh.2020.101509_bib21","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1590\/abd1806-4841.20153538","article-title":"Use of tumor necrosis factor alpha (TNF \u03b1) antagonists in a patient with psoriasis and Chagas disease","volume":"90","author":"Navarrete-Dechent","year":"2015","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.berh.2020.101509_bib22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1590\/S0074-02762008000400011","article-title":"TNF\/TNFR1 signaling up-regulates CCR5 expression by CD8 + T lymphocytes and promotes heart tissue damage during Trypanosoma cruzi infection: beneficial effects of TNF-\u03b1 blockade","volume":"103","author":"Kroll-Palhares","year":"2008","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.berh.2020.101509_bib23","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.cmi.2015.05.033","article-title":"Immunosuppression and Chagas disease; experience from a non-endemic country","volume":"21","author":"Salvador","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.berh.2020.101509_bib24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(17)31612-4","article-title":"Chagas disease","volume":"391","author":"P\u00e9rez-Molina","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2020.101509_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001965","article-title":"Immunosuppression and Chagas disease: a management challenge","volume":"7","author":"Pinazo","year":"2013","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.berh.2020.101509_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1590\/0037-8682-0505-2016","article-title":"2nd Brazilian consensus on Chagas disease, 2015","volume":"49","author":"Dias","year":"2016","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.berh.2020.101509_bib27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2249.2009.03946.x","article-title":"Short treatment with the tumour necrosis factor-\u03b1 blocker infliximab diminishes chronic chagasic myocarditis in rats without evidence of Trypanosoma cruzi reactivation","volume":"157","author":"P\u00e9rez","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.berh.2020.101509_bib28","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.exppara.2013.05.006","article-title":"Role of TNF in sickness behavior and allodynia during the acute phase of Chagas' disease","volume":"134","author":"Rodr\u00edguez-Angulo","year":"2013","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.berh.2020.101509_bib29","first-page":"205","article-title":"Etanercept induces low QRS voltage and autonomic dysfunction in mice with experimental Chagas disease","volume":"101","author":"Rodr\u00edguez-Angulo","year":"2013","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.berh.2020.101509_bib30","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1590\/abd1806-4841.20177346","article-title":"Reactivation of Chagas-Mazza disease during treatment with infliximab","volume":"92","author":"Vacas","year":"2017","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.berh.2020.101509_bib31","first-page":"752","article-title":"Recommendations for infectious disease screening in migrants to Western Europe with inflammatory arthropathies before starting biologic agents. Results from a multidisciplinary task force of four European societies (SIR, SER, SIMET, SEMTSI) facing the lar","volume":"35","author":"Bartalesi","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2020.101509_bib32","series-title":"WHO | the World malaria report 2018","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.berh.2020.101509_bib33","first-page":"1","article-title":"Indicadores de Vigil\u00e2ncia em Sa\u00fade descritos segundo a vari\u00e1vel ra\u00e7a\/cor, Brasil","volume":"48","year":"2017","journal-title":"Bol Epidemiol"},{"key":"10.1016\/j.berh.2020.101509_bib34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cll.2009.10.001","article-title":"Malaria","volume":"30","author":"Garcia","year":"2010","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.berh.2020.101509_bib35","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1086\/515402","article-title":"Overwhelming parasitemia with Plasmodium falciparum infection in a patient receiving infliximab therapy for rheumatoid arthritis","volume":"44","author":"Geraghty","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.berh.2020.101509_bib36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12016-010-8243-x","article-title":"Hydroxychloroquine: from malaria to autoimmunity","volume":"42","author":"Ben-Zvi","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.berh.2020.101509_bib37","doi-asserted-by":"crossref","first-page":"210","DOI":"10.7883\/yoken.JJID.2008.210","article-title":"The potential use of methotrexate in the treatment of falciparum malaria: in\u00a0vitro assays against sensitive and multidrug-resistant falciparum strains","volume":"61","author":"Dar","year":"2008","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.berh.2020.101509_bib38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1475-2875-8-102","article-title":"Azathioprine favourably influences the course of malaria","volume":"8","author":"Bobbala","year":"2009","journal-title":"Malar J"},{"key":"10.1016\/j.berh.2020.101509_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-13-476","article-title":"In\u00a0vitro activity of immunosuppressive drugs against Plasmodium falciparum","volume":"13","author":"Veletzky","year":"2014","journal-title":"Malar J"},{"key":"10.1016\/j.berh.2020.101509_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-10-63","article-title":"A\u00a0phase i trial to evaluate the safety and pharmacokinetics of low-dose methotrexate as an anti-malarial drug in Kenyan adult healthy volunteers","volume":"10","author":"Chilengi","year":"2011","journal-title":"Malar J"},{"issue":"2","key":"10.1016\/j.berh.2020.101509_bib41","first-page":"91","article-title":"Anti-TNF therapy inhibits fever in cerebral malaria","volume":"86","author":"Kwiatkowski","year":"1993","journal-title":"Q\u00a0J Med"},{"key":"10.1016\/j.berh.2020.101509_bib42","first-page":"160","article-title":"An atypical case of Plasmodium vivax malaria after initiating adalimumab therapy","volume":"19","author":"Shin","year":"2012","journal-title":"J\u00a0Rheum Dis"},{"key":"10.1016\/j.berh.2020.101509_bib43","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijid.2019.11.016","article-title":"Reactivation of Plasmodium infection during a treatment with Infliximab: a case report","volume":"91","author":"Haeseleer","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.berh.2020.101509_bib44","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2105\/AJPH.2018.304849","article-title":"Emerging and reemerging aedes-transmitted arbovirus infections in the region of the americas: implications for health policy","volume":"109","author":"Espinal","year":"2019","journal-title":"Am J Publ Health"},{"key":"10.1016\/j.berh.2020.101509_bib45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1574-695X.2003.tb00646.x","article-title":"Anti-TNF antibody treatment reduces mortality in experimental dengue virus infection","volume":"35","author":"Atrasheuskaya","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.berh.2020.101509_bib46","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1097\/MPG.0000000000000377","article-title":"Dengue hemorrhagic fever in a child with early-onset fistulizing Crohn disease under infliximab and azathioprine treatment","volume":"62","author":"Carvalho","year":"2016","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.berh.2020.101509_bib47","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jcv.2014.08.011","article-title":"Dengue fever in patients under biologics","volume":"61","author":"Deligny","year":"2014","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.berh.2020.101509_bib48","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ebiom.2016.11.017","article-title":"Zika virus infection in dexamethasone-immunosuppressed mice demonstrating disseminated infection with multi-organ involvement including orchitis effectively treated by recombinant type I interferons","volume":"14","author":"Chan","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.berh.2020.101509_bib49","series-title":"Neurological Syndrome, Congenital Malformations, and Zika Virus Infection. Implications for public health in the Americas","year":"2015"},{"key":"10.1016\/j.berh.2020.101509_bib50","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11882-017-0680-7","article-title":"Chikungunya infection: a global public health menace","volume":"17","author":"Mathew","year":"2017","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.berh.2020.101509_bib51","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.rbr.2017.05.004","article-title":"Recommendations of the Brazilian Society of Rheumatology for diagnosis and treatment of Chikungunya fever. Part 1 \u2013 diagnosis and special situations","volume":"57","author":"Marques","year":"2017","journal-title":"Rev Bras Reumatol"},{"key":"10.1016\/j.berh.2020.101509_bib52","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.cmi.2018.01.018","article-title":"Four-year safety follow-up of the tetravalent dengue vaccine efficacy randomized controlled trials in Asia and Latin America","volume":"24","author":"Arredondo-Garc\u00eda","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.berh.2020.101509_bib53","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/1941874417708129","article-title":"An overview of yellow fever virus disease","volume":"7","author":"McGuinness","year":"2017","journal-title":"The Neurohospitalist"},{"key":"10.1016\/j.berh.2020.101509_bib54","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.vaccine.2017.01.048","article-title":"Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation - a systematic review of randomized trials, observational studies and case re","volume":"35","author":"Croce","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.berh.2020.101509_bib55","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/art.38960","article-title":"Seroconversion in patients with rheumatic diseases treated with immunomodulators or immunosuppressants, who were inadvertently revaccinated against yellow fever","volume":"67","author":"Oliveira","year":"2015","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2020.101509_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rdc.2016.09.003","article-title":"Vaccines and disease-modifying antirheumatic drugs: practical implications for the rheumatologist","volume":"43","author":"Friedman","year":"2017","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.berh.2020.101509_bib57","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/jtm.12209","article-title":"Yellow fever vaccination of a primary vaccinee during adalimumab therapy","volume":"22","author":"Nash","year":"2015","journal-title":"J\u00a0Trav Med"},{"key":"10.1016\/j.berh.2020.101509_bib58","first-page":"389","article-title":"Weekly epidemiological record Relev\u00e9 \u00e9pid\u00e9miologique","volume":"94","author":"World Health Organization","year":"2019","journal-title":"hebdomadaire"},{"key":"10.1016\/j.berh.2020.101509_bib59","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.cmi.2019.05.020","article-title":"Diagnostic accuracy of tests for leprosy: a systematic review and meta-analysis","volume":"25","author":"Gurung","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.berh.2020.101509_bib60","series-title":"Accelerating towards a leprosy-free world. monitoring and evaluation guide. New Delhi: World Health Organization, Regional Office for South-East Asia","year":"2017"},{"key":"10.1016\/j.berh.2020.101509_bib61","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1590\/S0036-46652013000300006","article-title":"Active search for leprosy cases in midwestern Brazil: a serological evaluation of asymptomatic household contacts before and after prophylaxis with Bacillus Calmette-Gu\u00e9rin","volume":"55","author":"Limeira","year":"2013","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.berh.2020.101509_bib62","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1186\/s12879-018-3402-4","article-title":"An enhanced regimen as post-exposure chemoprophylaxis for leprosy: pep++","volume":"18","author":"Mieras","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.berh.2020.101509_bib63","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10067-009-1140-0","article-title":"Development of leprosy in a patient with ankylosing spondylitis during the infliximab treatment: reactivation of a latent infection?","volume":"28","author":"Vilela Lopes","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2020.101509_bib64","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1086\/505222","article-title":"Development of leprosy and type 1 leprosy reactions after treatment with infliximab: a report of 2 cases","volume":"43","author":"Scollard","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.berh.2020.101509_bib65","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/jid.1969.136","article-title":"Effects of methotrexate upon the experimental mitsuda Reaction\u2217\u2217From the departments of medical microbiology and Dermatology, Stanford University School of Medicine, Stanford, California 94305","volume":"53","author":"Goihman-Yahr","year":"1969","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.berh.2020.101509_bib66","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.semarthrit.2012.03.003","article-title":"Development of leprosy in a patient with rheumatoid arthritis during treatment with etanercept: a case report","volume":"42","author":"Lluch","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2020.101509_bib67","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/art.23815","article-title":"Type I reaction of Hansen's disease with exposure to adalimumab: a case report","volume":"59","author":"Oberstein","year":"2008","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2020.101509_bib68","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1590\/abd1806-4841.20175423","article-title":"Lepromatous leprosy simulating rheumatoid arthritis \u2013 report of a neglected disease","volume":"92","author":"de Andrade","year":"2017","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.berh.2020.101509_bib69","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1001\/archdermatol.2009.10","article-title":"Type 1 leprosy reaction manifesting after discontinuation of adalimumab therapy","volume":"145","author":"Camacho","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.berh.2020.101509_bib70","doi-asserted-by":"crossref","first-page":"S675","DOI":"10.1093\/ofid\/ofx163.1805","article-title":"A\u00a0randomized controlled trial of anti-TNF \u03b1 bio-similar adalimumab vs. Prednisolone in the management of leprosy patients with new type 1 lepra reaction","volume":"4","author":"Mitra","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.berh.2020.101509_bib71","first-page":"671935","article-title":"Demyelinating disease following anti-TNFa treatment: a causal or coincidental association? Report of four cases and review of the literature","volume":"2013","author":"Andreadou","year":"2013","journal-title":"Case Rep Neurol Med"},{"key":"10.1016\/j.berh.2020.101509_bib72","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1038\/cti.2017.34","article-title":"Inhibition of IL-17A by secukinumab shows no evidence of increased Mycobacterium tuberculosis infections","volume":"6","author":"Kamm\u00fcller","year":"2017","journal-title":"Clin Transl Immunol"},{"key":"10.1016\/j.berh.2020.101509_bib73","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/cid\/civ299","article-title":"Histoplasmosis complicating tumor necrosis factor-\u03b1 blocker therapy: a retrospective analysis of 98 cases","volume":"61","author":"Vergidis","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.berh.2020.101509_bib74","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.immuni.2013.12.002","article-title":"IL-17 regulates systemic fungal immunity by controlling the functional competence of NK Cells","volume":"40","author":"B\u00e4r","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.berh.2020.101509_bib75","first-page":"1","article-title":"Paracoccidioidomycosis in immunocompromised patients: a literature review","volume":"5","author":"de Almeida","year":"2019","journal-title":"J\u00a0Fungi"},{"key":"10.1016\/j.berh.2020.101509_bib76","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s15010-015-0799-1","article-title":"Strongyloides stercoralis hyperinfection syndrome: a case series and a review of the literature","volume":"43","author":"Geri","year":"2015","journal-title":"Infection"},{"key":"10.1016\/j.berh.2020.101509_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-13-78","article-title":"Severe strongyloidiasis: a systematic review of case reports","volume":"13","author":"Buonfrate","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.berh.2020.101509_bib78","first-page":"135","article-title":"Strongyloidiasis: a neglected tropical disease","volume":"33","author":"Krolewiecki","year":"2019","journal-title":"Infect Dis Clin"},{"key":"10.1016\/j.berh.2020.101509_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004898","article-title":"StrongNet: an international network to improve diagnostics and access to treatment for strongyloidiasis control","volume":"10","author":"Albonico","year":"2016","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.berh.2020.101509_bib80","series-title":"Diretrizes para a vigil\u00e2ncia, aten\u00e7\u00e3o e elimina\u00e7\u00e3o da Hansen\u00edase como problema de sa\u00fade p\u00fablica: manual t\u00e9cnico-operacional","author":"da Sa\u00fade","year":"2016"},{"key":"10.1016\/j.berh.2020.101509_bib81","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1708-8305.2006.00021.x","article-title":"The epidemiology, diagnosis, management, and prevention of ectoparasitic diseases in travelers","volume":"13","author":"Diaz","year":"2006","journal-title":"J\u00a0Trav Med"},{"key":"10.1016\/j.berh.2020.101509_bib82","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jaad.2004.12.039","article-title":"Crusted scabies in a patient being treated with infliximab for juvenile rheumatoid arthritis [14]","volume":"52","author":"Pipitone","year":"2005","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.berh.2020.101509_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006403","article-title":"Single-dose rifampicin chemoprophylaxis protects those who need it least and is not a cost-effective intervention","volume":"12","author":"Lockwood","year":"2018","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.berh.2020.101509_bib84","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/1756-185X.12644","article-title":"Strongyloides stercoralis infection in patients with systemic lupus erythematosus: diagnosis and prevention of severe strongyloidiasis","volume":"19","author":"de Souza","year":"2016","journal-title":"Int J Rheum Dis"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694220300267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694220300267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:21:36Z","timestamp":1761499296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694220300267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":84,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1521694220300267"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2020.101509","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opportunistic tropical infections in immunosuppressed patients","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2020.101509","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101509"}}